Singapore-state fund Temasek Holdings Ltd has increased its stake in Portola Pharmaceuticals, as per an SEC filing, which states that it now owns 11.8 per cent (96,583,568 shares) in the NASDAQ-listed pharma company.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
